Abstract

The application of recombinant immunotoxin and radioimmunoconjugate in Cancer therapy has revived the "magic bullet" concept predicted a century ago. Many of the recombinant antibodies have received FDA approval for various indication of cancer in recent years and numerous others are in clinical trials.

Keywords: Cancer therapy, recombinant immunotoxins, radioimmunoconjugates, engineered antibody, recombinant antibody